A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to compare the pharmacokinetic and safety of tegoprazan
following single oral dose in subjects with hepatic impairment versus healthy control.